1. Hypercalcaemia associated with calcipotriol (Dovonex) treatment;Hardman, K.A.; Heath, D.A.; Nelson, H.M.;BMJ,1993
2. Comparative study of calcipotriol (MC903) ointment and betamethasone 17-valerate in patients with psoriasis vulgaris;Cunliffe, W.J.; Berth-Jones, J.; Claudy, A.; Fairiss, G.; Goldin, D.; Gratton, D.;JAmAcad Dermatol,1992
3. A multicentre, parallel-group comparison ofcalcipotriol ointment and short-contact dithranol therapy in chronic plaque psoriasis;Berth-Jones, J.; Chu, A.C.; Dodd, W.A.H.; Ganpule, M.; Griffiths, W.A.D.; Haydey, R.P.;Br J Dermatol,1992
4. Efficacy and safety of calcipotriol (MC903) ointment in psoriasis vulgaris;Dubertet, L.; Wallach, D.; Souteyrand, P.; Perussel, M.; Kalis, B.; Meynadier, J.;J Am Acad Dermatol,1992
5. Pharinacokinetics of calcipotriol and 1,25(OH)2D3 in rats;Kissemeyer, A.M.; Binderup, L.,1991